相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer
Hui Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway
Dingqi Sun et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells
Ye Lei et al.
PLOS ONE (2015)
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2014)
Maspin influences response to doxorubicin by changing the tumor microenvironment organization
Tiziana Triulzi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line
Huihui Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Role of maspin in cancer
Rossana Berardi et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2013)
Maspin: molecular mechanisms and therapeutic implications
Thomas M. Bodenstine et al.
CANCER AND METASTASIS REVIEWS (2012)
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer
Iver Nordentoft et al.
BMC CANCER (2011)
Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder
Chih-Hao Sun et al.
HISTOPATHOLOGY (2011)
Update on Chemotherapy in the Treatment of Urothelial Carcinoma
Carrie Costantini et al.
THESCIENTIFICWORLDJOURNAL (2011)
Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells
Deyao Wu et al.
UROLOGIA INTERNATIONALIS (2011)
Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas
Nozomu Tanji et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy
Berta Ben Shachar et al.
MOLECULAR CANCER RESEARCH (2010)
Advanced bladder cancer: Status of first-line chemotherapy and the search for active agents in the second-line setting
David J. Gallagher et al.
CANCER (2008)
Curcumin and cancer: An old-age disease with an age-old solution
Preetha Anand et al.
CANCER LETTERS (2008)
Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells
Xiaohua Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway
Ling-Zhi Liu et al.
CANCER RESEARCH (2007)
Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors
A. Beltran et al.
ONCOGENE (2007)
Clinical relevance of maspin expression in bladder cancer
Wolf-D. Beecken et al.
WORLD JOURNAL OF UROLOGY (2006)
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates
P Surowiak et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
Akt-mediated cisplatin resistance in ovarian cancer: Modulation of p53 action on caspase-dependent mitocliondrial death pathway
XK Yang et al.
CANCER RESEARCH (2006)
Tumor suppressive maspin and epithelial homeostasis
J Lockett et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Targeting maspin in endothelial cells to induce cell apoptosis
Jeremy S. Schaefer et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis
A Tahmatzopoulos et al.
ONCOGENE (2005)
Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: Long-term maspin expression efficiently suppresses tumor growth
M Watanabe et al.
HUMAN GENE THERAPY (2005)
Expression and regulation gene maspin in human of tumor suppressor bladder cancer
S Sugimoto et al.
CANCER LETTERS (2004)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
Maspin sensitizes breast carcinoma cells to induced apoptosis
N Jiang et al.
ONCOGENE (2002)
Transurethral resection of muscle-invasive bladder cancer: 10-year outcome
HW Herr
JOURNAL OF CLINICAL ONCOLOGY (2001)
Maspin is an angiogenesis inhibitor
M Zhang et al.
NATURE MEDICINE (2000)
分享论文
